News Breaks |
|
|
| January 29, 2013 |
| 11:55 EDT |  | CELG, CELG, THLD, THLD, NLNK, NLNK | Cowen's biotech analyst research team holds an analyst/industry conference call
Biotech Analyst Research Team provides an update on pancreatic cancer with a focus on Celgene, Threshold Pharmaceuticals and NewLink Genetics on an Analyst/Industry conference call to be held on January 29 at 12 pm. |
|
|
News For CELG;THLD;NLNK From The Last 14 Days Check below for free stories on CELG;THLD;NLNK the last two weeks. |
|
|
| May 17, 2013 |
| 05:51 EDT |  | CELG | Stocks with implied volatility movement; CBST CELG
 Subscribe for More Information |
|
| May 16, 2013 |
| 15:11 EDT | | CELG | Celgene management to meet with JPMorgan
Subscribe for More Information |
|
| 11:50 EDT |  | CELG | Celgene, Gilead lower after new data published at ASCO
Subscribe for More Information |
|
| May 7, 2013 |
| 07:24 EDT | | THLD | Mizuho Securities to host a conference
Subscribe for More Information |
|
| 07:18 EDT |  | CELG | Barclays has increased confidence in Celgene's re-filing of Revlimid
Subscribe for More Information |
|
| May 6, 2013 |
| 14:33 EDT | | CELG | Celgene's apremilast had statistical significance for primary endpoint
Subscribe for More Information |
|
| 07:49 EDT |  | NLNK | NewLink Genetics reports Q1 EPS (33c), consensus (28c)
Subscribe for More Information |
|
|
|
|
|
